Bone Biologics Corp (BBLG):医療機器:M&Aディール及び事業提携情報

◆英語タイトル:Bone Biologics Corp (BBLG) - Medical Equipment - Deals and Alliances Profile
◆商品コード:DATA904C6556
◆発行会社(調査会社):GlobalData
◆発行日:2018年10月
◆ページ数:23
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:医療機器
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Bone Biologics Corp (Bone Biologics) is a biotechnology company that develops orthobiologic products. The company develops NELL-1, a recombinant human protein growth factor, which is essential for normal bone development. It offers bone graft substitutes for spine fusion. Bone Biologics also offers Nell-1/TCP fusion device, which is a single dose vial of Nell-1 recombinant protein freeze dried onto tricalcium phosphate and demineralized bone putty. The company’s technology has application in spinal, orthopedic, general orthopedic, plastic reconstruction, neurosurgery, interventional radiology, and sports medicines. It collaborates with manufacturing organizations to develop its products. The company markets its products domestic and internationally. Bone Biologics is headquartered in Burlington, Massachusetts, the US.

Bone Biologics Corp (BBLG) – Medical Equipment – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Medical eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Bone Biologics Corp, Medical Equipment, Deals By Year, 2012 to YTD 2018 5
Bone Biologics Corp, Medical Equipment Deals By Type, 2012 to YTD 2018 6
Bone Biologics Corp, Medical Equipment, Deals By Region, 2012 to YTD 2018 7
Bone Biologics Corp, Medical Equipment, Deals By Market, 2012 to YTD 2018 8
Bone Biologics Corp, Medical Equipment, Deals Summary, 2012 to YTD 2018 9
Bone Biologics Corp, Medical Equipment, Deal Details 10
Venture Financing 10
Bone Biologics Raises USD5.75 Million in Venture Financing 10
Bone Biologics Raises USD5 Million in Venture Financing 11
Partnerships 12
Bone Biologics Enters into Option Agreement with UCLA 12
Merger 13
AFH Acquisition Merges with Bone Biologics in Reverse Merger Transaction 13
Equity Offering 14
Bone Biologics Raises USD3.9 Million in Private Placement of Shares 14
Bone Biologics Raises USD0.5 million in Second Tranche of Financing 15
Bone Biologics Raises USD0.7 Million in First Tranche of Private Placement of Shares 16
Debt Offering 17
Bone Biologics Raises USD2 Million in Private Placement of 8.5% Notes Due 2019 17
Bone Biologics Raises USD0.7 Million in First Tranche of Private Placement of 8.5% Convertible Promissory Note Due 2017 18
Bone Biologics Corp – Key Competitors 19
Bone Biologics Corp – Key Employees 20
Bone Biologics Corp – Locations And Subsidiaries 21
Head Office 21
Recent Developments 22
Corporate Communications 22
Aug 03, 2017: Bone Biologics Announces Appointment of Bret Hankey to Company’s Board of Director 22
Appendix 23
Methodology 23
About GlobalData 23
Contact Us 23
Disclaimer 23

List of Tables
Bone Biologics Corp, Medical Equipment, Key Facts, 2017 2
Bone Biologics Corp, Medical Equipment, Deals Summary, 2012 to YTD 2018 2
Bone Biologics Corp, Medical Equipment, Deals By Year, 2012 to YTD 2018 5
Bone Biologics Corp, Medical Equipment Deals By Type, 2012 to YTD 2018 6
Bone Biologics Corp, Medical Equipment, Deals By Region, 2012 to YTD 2018 7
Bone Biologics Corp, Deals By Market, 2012 to YTD 2018 8
Bone Biologics Corp, Medical Equipment, Deals Summary, 2012 to YTD 2018 9
Bone Biologics Raises USD5.75 Million in Venture Financing 10
Bone Biologics Raises USD5 Million in Venture Financing 11
Bone Biologics Enters into Option Agreement with UCLA 12
AFH Acquisition Merges with Bone Biologics in Reverse Merger Transaction 13
Bone Biologics Raises USD3.9 Million in Private Placement of Shares 14
Bone Biologics Raises USD0.5 million in Second Tranche of Financing 15
Bone Biologics Raises USD0.7 Million in First Tranche of Private Placement of Shares 16
Bone Biologics Raises USD2 Million in Private Placement of 8.5% Notes Due 2019 17
Bone Biologics Raises USD0.7 Million in First Tranche of Private Placement of 8.5% Convertible Promissory Note Due 2017 18
Bone Biologics Corp, Key Competitors 19
Bone Biologics Corp, Key Employees 20

List of Figures
Bone Biologics Corp, Medical Equipment, Deals by Type, 2012 to YTD 2018 2
Bone Biologics Corp, Medical Equipment, Deals By Year, 2012 to YTD 2018 2
Bone Biologics Corp, Medical Equipment, Deals By Region, 2012 to YTD 2018 2
Bone Biologics Corp, Medical Equipment, Deals By Market, 2012 to YTD 2018 2
Bone Biologics Corp, Medical Equipment, Deals By Year, 2012 to YTD 2018 5
Bone Biologics Corp, Medical Equipment, Deals by Type, 2012 to YTD 2018 6
Bone Biologics Corp, Medical Equipment, Deals By Region, 2012 to YTD 2018 7
Bone Biologics Corp, Medical Equipment, Deals by Market, 2012 to YTD 2018 8

★海外企業調査レポート[Bone Biologics Corp (BBLG):医療機器:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Enel Green Power SpA:企業の戦略的SWOT分析
    Enel Green Power SpA - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and s …
  • Mitsubishi Logistics Corporation (9301):企業の財務・戦略的SWOT分析
    Mitsubishi Logistics Corporation (9301) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths …
  • Novo Nordisk A/S:企業のM&A・事業提携・投資動向
    Novo Nordisk A/S - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Novo Nordisk A/S Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), dives …
  • Consolidated Construction Consortium Limited:企業の戦略・SWOT・財務情報
    Consolidated Construction Consortium Limited - Strategy, SWOT and Corporate Finance Report Summary Consolidated Construction Consortium Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operati …
  • Bellvitge Biomedical Research Institute:製薬・医療:M&Aディール及び事業提携情報
    Summary Bellvitge Biomedical Research Institute (IDIBELL) is a biomedical research center that offers health care development solutions. The center conducts clinical and basic research for developing treatments and techniques to improve health care. It offers its research work in the fields of neuro …
  • XState Resources Ltd (XST):企業の財務・戦略的SWOT分析
    Summary XState Resources Ltd (XState Resources) is an oil and gas exploration and development company. The company’s business activities include acquisition, exploration, production and development of oil and gas assets. It holds interest in producing gas wells and associated land leases and product …
  • Layne Christensen Co (LAYN):石油・ガス:M&Aディール及び事業提携情報
    Summary Layne Christensen Company (Layne) is a water management, construction and drilling company. It provides solutions to essential natural resources such as water, mineral and energy. The company’s service portfolio includes hydrological studies, site selection, well design, drilling, well rehab …
  • Television Francaise 1 SA:企業の戦略・SWOT・財務情報
    Television Francaise 1 SA - Strategy, SWOT and Corporate Finance Report Summary Television Francaise 1 SA - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service …
  • Apache Corp (APA):石油・ガス:M&Aディール及び事業提携情報
    Summary Apache Corp (Apache) is an independent upstream energy company, which carries out exploration, development and production of natural gas, crude oil and natural gas liquids (NGLs). It has onshore and offshore asset base consisting of operations in the Permian Basin, the Anadarko basin in west …
  • Envestnet, Inc.:企業のM&A・事業提携・投資動向
    Envestnet, Inc. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Envestnet, Inc. Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), divestm …
  • Toyo Seikan Group Holdings, Ltd.
    Toyo Seikan Group Holdings, Ltd. - Strategy, SWOT and Corporate Finance Report Summary Toyo Seikan Group Holdings, Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, produ …
  • CytoBioscience Inc:医療機器:M&Aディール及び事業提携情報
    Summary CytoBioscience Inc (CytoBioscience), formerly Cytocentrics Bioscience GmbH is a biotechnology company that manufactures of medical devices for ion channel research. The company’s products include CytoPatch instrumentations. It provides services such as adult human heart, expression systems, …
  • Stellar Biotechnologies Inc (SBOT):製薬・医療:M&Aディール及び事業提携情報
    Summary Stellar Biotechnologies Inc (Stellar Bio), formerly CAG Capital Inc is a provider of keyhole limpet hemocyanin proteins. The company offers potent immune-stimulating molecule used as an active pharmaceutical ingredient known as active immunotherapies or therapeutic vaccines and as an injecta …
  • Darden Restaurants, Inc. (DRI):企業の財務・戦略的SWOT分析
    Darden Restaurants, Inc. (DRI) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakn …
  • Palram Industries Ltd (PLRM):企業の財務・戦略的SWOT分析
    Palram Industries Ltd (PLRM) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknes …
  • Intesa Sanpaolo S.p.A:企業のM&A・事業提携・投資動向
    Intesa Sanpaolo S.p.A - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Intesa Sanpaolo S.p.A Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M …
  • Cre8tek Ltd (FGO):石油・ガス:M&Aディール及び事業提携情報
    Summary Cre8tek Ltd (Cre8tek), formerly Marion Energy Ltd, is an oil and gas exploration and production company. The company explores, acquires, develops, produces and markets oil and gas. It has core operations in Clear Creek field located in the Uinta Basin. Cre8tek also holds interest in the addi …
  • Potlatch Corporation:戦略・SWOT・企業財務分析
    Potlatch Corporation - Strategy, SWOT and Corporate Finance Report Summary Potlatch Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings …
  • Thai Vegetable Oil Public Company Limited:企業の戦略・SWOT・財務情報
    Thai Vegetable Oil Public Company Limited - Strategy, SWOT and Corporate Finance Report Summary Thai Vegetable Oil Public Company Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SW …
  • Liquor Control Board of Ontario:企業の戦略的SWOT分析
    Liquor Control Board of Ontario - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major pro …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆